Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Terminated 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Medulloblastoma 1

Interventions

Specimen Handling 219 Magnetic Resonance Spectroscopy 196 pembrolizumab 195 Carboplatin 169 Cisplatin 137 Biopsy 130 Nivolumab 127 Paclitaxel 112 Cyclophosphamide 109 Radiotherapy 104 Gemcitabine 103 durvalumab 88 Dexamethasone 88 atezolizumab 75 Rituximab 69 Radiation 67 Lenalidomide 67 Pemetrexed 65 Doxorubicin 64 Bevacizumab 64 Docetaxel 61 Etoposide 57 Ipilimumab 56 olaparib 54 Fluorouracil 50 Prednisone 49 Oxaliplatin 49 venetoclax 48 Taxes 48 Radiosurgery 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Diphtheria-Tetanus Vaccine × 90 days × Clear all

NCT06514898 2026-04-03

MATCHPOINT

University of Florida

Phase 1 Active not recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡